Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Research

High neutrophils and low lymphocytes percentages in bronchoalveolar lavage fluid are prognostic factors of higher in-hospital mortality in diffuse alveolar hemorrhage

Authors: Kensuke Kanaoka, Seigo Minami, Shoichi Ihara, Kiyoshi Komuta

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Diffuse alveolar hemorrhage (DAH) is a syndrome resulting from bleeding in the microcirculation of the lung, with a poor prognosis. The study aim was to identify prognostic factors of DAH, especially bronchoalveolar lavage fluids (BALF) cell pattern.

Methods

We conducted a single-center retrospective cohort study of patients diagnosed as having DAH and hospitalized at our hospital between October 2008 and July 2020. We performed univariate logistic regressions to identify variables associated with in-hospital death.

Results

Sixty-eight patients were included in our analysis. In-hospital mortality was 26.5%. Variables associated with in-hospital death were neutrophils percentage in BALF ≥ 44.5% [Odds Ratio (OR) 16.0, 95% confidence interval (CI) 4.33–58.9)], lymphocytes percentage in BALF < 14% (OR 7.44, 95% CI 2.11–26.2), idiopathic DAH (OR 0.31, 95% CI 0.10–0.95), oxygen flow ≥ 4L/min (OR 3.90, 95% CI 1.20–12.6), and estimated glomerular filtration rate < 60 mL/min (OR 5.00, 95%CI 1.29–19.4).

Conclusions

High neutrophils and low lymphocytes percentages in BALF were associated with poor prognosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010;137:1164–71.CrossRef Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010;137:1164–71.CrossRef
2.
go back to reference De Prost N, Parrot A, Picard C, Ancel PY, Mayaud C, Fartoukh M, et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J. 2010;35:1303–11.CrossRef De Prost N, Parrot A, Picard C, Ancel PY, Mayaud C, Fartoukh M, et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J. 2010;35:1303–11.CrossRef
3.
go back to reference Rabe C, Appenrodt B, Hoff C, Ewig S, Ulrich H, Sauerbruch T, et al. Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care. 2010;25:230–5.CrossRef Rabe C, Appenrodt B, Hoff C, Ewig S, Ulrich H, Sauerbruch T, et al. Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care. 2010;25:230–5.CrossRef
4.
go back to reference De PN, Parrot A, Cuquemelle E, Mayaud C, Boffa J, Fartoukh M, et al. Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited. Respir Med. 2012;106:1021–32.CrossRef De PN, Parrot A, Cuquemelle E, Mayaud C, Boffa J, Fartoukh M, et al. Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited. Respir Med. 2012;106:1021–32.CrossRef
5.
go back to reference Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, Géri G, et al. Severe diffuse alveolar hemorrhage related to autoimmune disease : a multicenter study. Crit Care. 2020;24:1–10.CrossRef Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, Géri G, et al. Severe diffuse alveolar hemorrhage related to autoimmune disease : a multicenter study. Crit Care. 2020;24:1–10.CrossRef
6.
go back to reference Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, Géri G, et al. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study. Curr Probl Diagn Radiol. 2020;24:1–10. Mirouse A, Parrot A, Audigier V, Demoule A, Mayaux J, Géri G, et al. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study. Curr Probl Diagn Radiol. 2020;24:1–10.
7.
go back to reference Nasser M, Cottin V. Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med. 2018;39:482–93.CrossRef Nasser M, Cottin V. Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med. 2018;39:482–93.CrossRef
8.
go back to reference Schwarz MI, Fontenot AP. Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med. 2004;25:133–40.CrossRef Schwarz MI, Fontenot AP. Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med. 2004;25:133–40.CrossRef
9.
go back to reference Otoshi T, Kataoka Y, Nakagawa A, Otsuka K, Tomii K. Clinical features and outcomes of diffuse alveolar hemorrhage during antithrombotic therapy: a retrospective cohort study. Lung. 2016;194:475–81.CrossRef Otoshi T, Kataoka Y, Nakagawa A, Otsuka K, Tomii K. Clinical features and outcomes of diffuse alveolar hemorrhage during antithrombotic therapy: a retrospective cohort study. Lung. 2016;194:475–81.CrossRef
10.
go back to reference Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2016;128:1300–5.CrossRef Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2016;128:1300–5.CrossRef
11.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef
12.
go back to reference Twaddell SH, Baines KJ, Grainge C, Gibson PG. The emerging role of neutrophil extracellular traps in respiratory disease. Chest. 2019;156:774–82.CrossRef Twaddell SH, Baines KJ, Grainge C, Gibson PG. The emerging role of neutrophil extracellular traps in respiratory disease. Chest. 2019;156:774–82.CrossRef
13.
go back to reference Bendib I, De Chaisemartin L, Granger V, Schlemmer F, Maitre B, Hüe S, et al. Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome. Anesthesiology. 2019;130:581–91.CrossRef Bendib I, De Chaisemartin L, Granger V, Schlemmer F, Maitre B, Hüe S, et al. Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome. Anesthesiology. 2019;130:581–91.CrossRef
14.
go back to reference Lefrançais E, Mallavia B, Zhuo H, Calfee CS, Looney MR. Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI insight. 2018;3:1–15.CrossRef Lefrançais E, Mallavia B, Zhuo H, Calfee CS, Looney MR. Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI insight. 2018;3:1–15.CrossRef
15.
go back to reference Li H, Zhou X, Tan H, Hu Y, Zhang L, Liu S, et al. Neutrophil extracellular traps contribute to the pathogenesis of acid-aspiration-induced ALI/ARDS. Oncotarget. 2018;9:1772–84.CrossRef Li H, Zhou X, Tan H, Hu Y, Zhang L, Liu S, et al. Neutrophil extracellular traps contribute to the pathogenesis of acid-aspiration-induced ALI/ARDS. Oncotarget. 2018;9:1772–84.CrossRef
16.
go back to reference Ebrahimi F, Giaglis S, Hahn S, Blum CA, Baumgartner C, Kutz A, et al. Markers of neutrophil extracellular traps predict adverse outcome in communityacquired pneumonia: secondary analysis of a randomised controlled trial. Eur Respir J. 2018;51:1701389.CrossRef Ebrahimi F, Giaglis S, Hahn S, Blum CA, Baumgartner C, Kutz A, et al. Markers of neutrophil extracellular traps predict adverse outcome in communityacquired pneumonia: secondary analysis of a randomised controlled trial. Eur Respir J. 2018;51:1701389.CrossRef
17.
go back to reference Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, Bois RM, et al. American thoracic society documents an official American Thoracic Society Clinical Practice Guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004–14.CrossRef Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, Bois RM, et al. American thoracic society documents an official American Thoracic Society Clinical Practice Guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004–14.CrossRef
18.
go back to reference Parambil JG, Myers JL, Aubry MC, Ryu JH. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest. 2007;132:50–7.CrossRef Parambil JG, Myers JL, Aubry MC, Ryu JH. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest. 2007;132:50–7.CrossRef
19.
go back to reference Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci. 2005;42:71–104.CrossRef Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci. 2005;42:71–104.CrossRef
20.
go back to reference Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Eur Respir J. 2011;38:761–9.CrossRef Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Eur Respir J. 2011;38:761–9.CrossRef
21.
go back to reference Wells AU, Hirani N. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(Suppl):5. Wells AU, Hirani N. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(Suppl):5.
22.
go back to reference Hirasawa Y, Nakada T, Shimazui T, Abe M, Isaka Y, Sakayori M, et al. Prognostic value of lymphocyte counts in bronchoalveolar lavage fluid in patients with acute respiratory failure: a retrospective cohort study. J Intensive Care. 2021;9:1–7.CrossRef Hirasawa Y, Nakada T, Shimazui T, Abe M, Isaka Y, Sakayori M, et al. Prognostic value of lymphocyte counts in bronchoalveolar lavage fluid in patients with acute respiratory failure: a retrospective cohort study. J Intensive Care. 2021;9:1–7.CrossRef
23.
go back to reference Takei R, Arita M, Kumagai S, Ito Y, Noyama M, Tokioka F, et al. Impact of lymphocyte differential count > 15 % in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia. BMC Pulm Med. 2017;67:1–8. Takei R, Arita M, Kumagai S, Ito Y, Noyama M, Tokioka F, et al. Impact of lymphocyte differential count > 15 % in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia. BMC Pulm Med. 2017;67:1–8.
24.
go back to reference Hillege HL, Girbes ARJ, De KPJ, Boomsma F, De ZD, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203–10.CrossRef Hillege HL, Girbes ARJ, De KPJ, Boomsma F, De ZD, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203–10.CrossRef
25.
go back to reference Sirvent JM, De Torre MC, Lorencio C, Taché A, Ferri C, Garcia-Gil J, et al. Predictive factors of mortality in severe community-acquired pneumonia: a model with data on the first 24 h of ICU admission. Med Intensiva. 2013;37:308–15.CrossRef Sirvent JM, De Torre MC, Lorencio C, Taché A, Ferri C, Garcia-Gil J, et al. Predictive factors of mortality in severe community-acquired pneumonia: a model with data on the first 24 h of ICU admission. Med Intensiva. 2013;37:308–15.CrossRef
26.
go back to reference Titeca-beauport D, Francois A, Lobbedez T, Guerrot D, Launay D, Vrigneaud L, et al. Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study. BMC Nephrol. 2018;19:1–9.CrossRef Titeca-beauport D, Francois A, Lobbedez T, Guerrot D, Launay D, Vrigneaud L, et al. Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study. BMC Nephrol. 2018;19:1–9.CrossRef
Metadata
Title
High neutrophils and low lymphocytes percentages in bronchoalveolar lavage fluid are prognostic factors of higher in-hospital mortality in diffuse alveolar hemorrhage
Authors
Kensuke Kanaoka
Seigo Minami
Shoichi Ihara
Kiyoshi Komuta
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01660-x

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.